Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Vyse, S. Huang, P.H. (2022). Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer. Expert rev anticancer ther, Vol.22 (1), pp. 3-16.  show abstract

Chadha, M. Huang, P.H. (2022). Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas. Curr treat options oncol, Vol.23 (1), pp. 78-88.  show abstract

Smrke, A. Frezza, A.M. Giani, C. Somaiah, N. Brahmi, M. Czarnecka, A.M. Rutkowski, P. Van der Graaf, W. Baldi, G.G. Connolly, E. Duffaud, F. Huang, P.H. Gelderblom, H. Bhadri, V. Grimison, P. Mahar, A. Stacchiotti, S. Jones, R.L. (2022). Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network. Esmo open, Vol.7 (3), pp. 100522-100522.

Burns, J. Brown, J.M. Jones, K.B. Huang, P.H. (2022). The Cancer Genome Atlas. Surgical oncology clinics of north america, Vol.31 (3), pp. 559-568.

Pacini, L. Cabal, V.N. Hermsen, M.A. Huang, P.H. (2022). EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma. Cancers (basel), Vol.14 (2).  show abstract

Krasny, L. Wilding, C.P. Perkins, E. Arthur, A. Guljar, N. Jenks, A.D. Fisher, C. Judson, I. Thway, K. Jones, R.L. Huang, P.H. (2022). Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers (basel), Vol.14 (12).  show abstract

Frankel, A.O. Lathara, M. Shaw, C.Y. Wogmon, O. Jackson, J.M. Clark, M.M. Eshraghi, N. Keenen, S.E. Woods, A.D. Purohit, R. Ishi, Y. Moran, N. Eguchi, M. Ahmed, F.U. Khan, S. Ioannou, M. Perivoliotis, K. Li, P. Zhou, H. Alkhaledi, A. Davis, E.J. Galipeau, D. Randall, R.L. Wozniak, A. Schoffski, P. Lee, C.-. Huang, P.H. Jones, R.L. Rubin, B.P. Darrow, M. Srinivasa, G. Rudzinski, E.R. Chen, S. Berlow, N.E. Keller, C. (2022). Machine learning for rhabdomyosarcoma histopathology. Mod pathol, .  show abstract

Kerrison, W.G. Lee, A.T. Thway, K. Jones, R.L. Huang, P.H. (2022). Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas. Biomedicines, Vol.10 (3).  show abstract

Napolitano, A. Thway, K. Smith, M.J. Huang, P.H. Jones, R.L. (2022). KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment. Chemotherapy, Vol.67 (2), pp. 81-90.  show abstract

Phillips, E. Jones, R.L. Huang, P. Digklia, A. (2022). Efficacy of Eribulin in Soft Tissue Sarcomas. Front pharmacol, Vol.13, p. 869754.  show abstract

(2022). Systemic therapy is effective in the management of leiomyomatosis. European journal of gynaecological oncology, Vol.43 (3), pp. 83-83.

Krasny, L. Huang, P.H. (2021). Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Mol omics, Vol.17 (1), pp. 29-42.  show abstract

Stacchiotti, S. Miah, A.B. Frezza, A.M. Messiou, C. Morosi, C. Caraceni, A. Antonescu, C.R. Bajpai, J. Baldini, E. Bauer, S. Biagini, R. Bielack, S. Blay, J.Y. Bonvalot, S. Boukovinas, I. Bovee, J.V. Boye, K. Brodowicz, T. Callegaro, D. De Alava, E. Deoras-Sutliff, M. Dufresne, A. Eriksson, M. Errani, C. Fedenko, A. Ferraresi, V. Ferrari, A. Fletcher, C.D. Garcia Del Muro, X. Gelderblom, H. Gladdy, R.A. Gouin, F. Grignani, G. Gutkovich, J. Haas, R. Hindi, N. Hohenberger, P. Huang, P. Joensuu, H. Jones, R.L. Jungels, C. Kasper, B. Kawai, A. Le Cesne, A. Le Grange, F. Leithner, A. Leonard, H. Lopez Pousa, A. Martin Broto, J. Merimsky, O. Merriam, P. Miceli, R. Mir, O. Molinari, M. Montemurro, M. Oldani, G. Palmerini, E. Pantaleo, M.A. Patel, S. Piperno-Neumann, S. Raut, C.P. Ravi, V. Razak, A.R. Reichardt, P. Rubin, B.P. Rutkowski, P. Safwat, A.A. Sangalli, C. Sapisochin, G. Sbaraglia, M. Scheipl, S. Schöffski, P. Strauss, D. Strauss, S.J. Sundby Hall, K. Tap, W.D. Trama, A. Tweddle, A. van der Graaf, W.T. Van De Sande, M.A. Van Houdt, W. van Oortmerssen, G. Wagner, A.J. Wartenberg, M. Wood, J. Zaffaroni, N. Zimmermann, C. Casali, P.G. Dei Tos, A.P. Gronchi, A. (2021). Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. Esmo open, Vol.6 (3), pp. 100170-?.  show abstract

Merry, E. Thway, K. Jones, R.L. Huang, P.H. (2021). Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas. Npj precis oncol, Vol.5 (1), p. 17.  show abstract

Cojocaru, E. Palahepitiva Gamage, G. Butler, J. Barton, D.P. Thway, K. Fisher, C. Messiou, C. Miah, A.B. Zaidi, S. Gennatas, S. Benson, C. Huang, P. Jones, R.L. (2021). Clinical management and outcomes of primary ovarian leiomyosarcoma - Experience from a sarcoma specialist unit. Gynecol oncol rep, Vol.36, p. 100737.  show abstract

Chamberlain, F. Benson, C. Thway, K. Huang, P. Jones, R.L. Gennatas, S. (2021). Pharmacotherapy for liposarcoma: current and emerging synthetic treatments. Future oncol, Vol.17 (20), pp. 2659-2670.  show abstract

Krasny, L. Huang, P.H. (2021). Advances in the proteomic profiling of the matrisome and adhesome. Expert rev proteomics, Vol.18 (9), pp. 781-794.  show abstract

Smrke, A. Thway, K. H Huang, P. Jones, R.L. Hayes, A.J. (2021). Solitary fibrous tumor: molecular hallmarks and treatment for a rare sarcoma. Future oncol, Vol.17 (27), pp. 3627-3636.  show abstract

Pacini, L. Jenks, A.D. Lima, N.C. Huang, P.H. (2021). Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer. Cells, Vol.10 (5).  show abstract

Smrke, A. Benson, C. Strauss, D.C. Hayes, A.J. Thway, K. Hallin, M. Fisher, C. Messiou, C. Huang, P.H. Jones, R.L. Smith, M.J. (2021). Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments. Eur j surg oncol, Vol.47 (10), pp. 2595-2601.  show abstract

Alves, A. Constantinidou, A. Thway, K. Fisher, C. Huang, P. Jones, R.L. (2021). The evolving management of epithelioid sarcoma. Eur j cancer care (engl), Vol.30 (6), p. e13489.

Smrke, A. Tam, Y.B. Anderson, P.M. Jones, R.L. Huang, P.H. (2021). The perplexing role of immuno-oncology drugs in osteosarcoma. J bone oncol, Vol.31, p. 100400.  show abstract

Smrke, A.M. Huang, P.H. Jones, R.L. (2021). Sirolimus for patients with progressive epithelioid hemangioendothelioma. Cancer, Vol.127 (4), pp. 504-506.

Smrke, A. Anderson, P.M. Gulia, A. Gennatas, S. Huang, P.H. Jones, R.L. (2021). Future Directions in the Treatment of Osteosarcoma. Cells, Vol.10 (1).  show abstract

Milighetti, M. Krasny, L. Lee, A.T. Morani, G. Szecsei, C. Chen, Y. Guljar, N. McCarthy, F. Wilding, C.P. Arthur, A. Fisher, C. Judson, I. Thway, K. Cheang, M.C. Jones, R.L. Huang, P.H. (2021). Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry. J proteomics, Vol.241, p. 104236.  show abstract

Napolitano, A. Ostler, A.E. Jones, R.L. Huang, P.H. (2021). Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas. Cells, Vol.10 (6).  show abstract

Kasper, B. Achee, A. Schuster, K. Wilson, R. van Oortmerssen, G. Gladdy, R.A. Hemming, M.L. Huang, P. Ingham, M. Jones, R.L. Pollack, S.M. Reinke, D. Sanfilippo, R. Schuetze, S.M. Somaiah, N. Van Tine, B.A. Wilky, B. Okuno, S. Trent, J. (2021). Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN). Cancers (basel), Vol.13 (4).  show abstract

Peck, B. Bland, P. Mavrommati, I. Muirhead, G. Cottom, H. Wai, P.T. Maguire, S.L. Barker, H.E. Morrison, E. Kriplani, D. Yu, L. Gibson, A. Falgari, G. Brennan, K. Farnie, G. Buus, R. Marlow, R. Novo, D. Knight, E. Guppy, N. Kolarevic, D. Susnjar, S. Milijic, N.M. Naidoo, K. Gazinska, P. Roxanis, I. Pancholi, S. Martin, L.-. Holgersen, E.M. Cheang, M.C. Noor, F. Postel-Vinay, S. Quinn, G. McDade, S. Krasny, L. Huang, P. Daley, F. Wallberg, F. Choudhary, J.S. Haider, S. Tutt, A.N. Natrajan, R. (2021). 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer. Cancer research, .  show abstract

Vyse, S. Thway, K. Huang, P.H. Jones, R.L. (2021). Next-generation sequencing for the management of sarcomas with no known driver mutations. Current opinion in oncology, .  show abstract

Pacini, L. Jenks, A.D. Vyse, S. Wilding, C.P. Arthur, A. Huang, P.H. (2021). Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer. Pharmgenomics pers med, Vol.14, pp. 301-317.  show abstract

Pankova, V. Thway, K. Jones, R.L. Huang, P.H. (2021). The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling. Front cell dev biol, Vol.9, p. 763640.  show abstract

Lima, N.C. Atkinson, E. Bunney, T.D. Katan, M. Huang, P.H. (2020). Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations. Int j mol sci, Vol.21 (9).  show abstract

Cojocaru, E. Wilding, C. Engelman, B. Huang, P. Jones, R.L. (2020). Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?. Current molecular biology reports, Vol.6 (1), pp. 1-9.  show abstract

Harrison, P.T. Vyse, S. Huang, P.H. (2020). Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Seminars in cancer biology, Vol.61, pp. 167-179.  show abstract

Burns, J. Wilding, C.P. L Jones, R. H Huang, P. (2020). Proteomic research in sarcomas - current status and future opportunities. Seminars in cancer biology, Vol.61, pp. 56-70.  show abstract

Wilding, C.P. Loong, H.H. Huang, P.H. Jones, R.L. (2020). Tropomyosin receptor kinase inhibitors in the management of sarcomas. Current opinion in oncology, Vol.32 (4), pp. 307-313.  show abstract

Smrke, A. Gennatas, S. Huang, P. Jones, R.L. (2020). Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumors. Future oncol, Vol.16 (22), pp. 1639-1646.  show abstract

Chen, T.W. Burns, J. Jones, R.L. Huang, P.H. (2020). Optimal Clinical Management and the Molecular Biology of Angiosarcomas. Cancers (basel), Vol.12 (11).  show abstract

Cojocaru, E. Thway, K. Fisher, C. Messiou, C. Zaidi, S. Miah, A.B. Benson, C. Gennatas, S. Huang, P. Jones, R.L. (2020). Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft Tissue. Anticancer research, Vol.40 (12), pp. 7003-7007.  show abstract

Krasny, L. Bland, P. Burns, J. Lima, N.C. Harrison, P.T. Pacini, L. Elms, M.L. Ning, J. Martinez, V.G. Yu, Y.-. Acton, S.E. Ho, P.-. Calvo, F. Swain, A. Howard, B.A. Natrajan, R.C. Huang, P.H. (2020). A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts. Dis model mech, Vol.13 (7).  show abstract

Vyse, S. Huang, P.H. (2019). Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. Signal transduction and targeted therapy, Vol.4, pp. 5-?.  show abstract

Lee, A.T. Jones, R.L. Huang, P.H. (2019). Pazopanib in advanced soft tissue sarcomas. Signal transduction and targeted therapy, Vol.4, pp. 16-?.  show abstract

Chamberlain, F.E. Wilding, C. Jones, R.L. Huang, P. (2019). Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. Expert opinion on investigational drugs, Vol.28 (6), pp. 505-511.  show abstract

Lee, A.T. Chew, W. Wilding, C.P. Guljar, N. Smith, M.J. Strauss, D.C. Fisher, C. Hayes, A.J. Judson, I. Thway, K. Jones, R.L. Huang, P.H. (2019). The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma. Scientific reports, Vol.9 (1), pp. 14602-?.  show abstract

Martinez, V.G. Pankova, V. Krasny, L. Singh, T. Makris, S. White, I.J. Benjamin, A.C. Dertschnig, S. Horsnell, H.L. Kriston-Vizi, J. Burden, J.J. Huang, P.H. Tape, C.J. Acton, S.E. (2019). Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion. Cell reports, Vol.29 (9), pp. 2810-2822.e5.  show abstract

Wilding, C.P. Elms, M.L. Judson, I. Tan, A.-. Jones, R.L. Huang, P.H. (2019). The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib. Expert review of anticancer therapy, Vol.19 (11), pp. 971-991.  show abstract

Lee, A.T. Thway, K. Huang, P.H. Jones, R.L. (2018). Clinical and Molecular Spectrum of Liposarcoma. Journal of clinical oncology : official journal of the american society of clinical oncology, Vol.36 (2), pp. 151-159.  show abstract

Vyse, S. McCarthy, F. Broncel, M. Paul, A. Wong, J.P. Bhamra, A. Huang, P.H. (2018). Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. Journal of proteomics, Vol.170, pp. 130-140.  show abstract

Antoniou, G. Lee, A.T. Huang, P.H. Jones, R.L. (2018). Olaratumab in soft tissue sarcoma - Current status and future perspectives. European journal of cancer (oxford, england : 1990), Vol.92, pp. 33-39.  show abstract

Jenks, A.D. Vyse, S. Wong, J.P. Kostaras, E. Keller, D. Burgoyne, T. Shoemark, A. Tsalikis, A. de la Roche, M. Michaelis, M. Cinatl, J. Huang, P.H. Tanos, B.E. (2018). Primary Cilia Mediate Diverse Kinase Inhibitor Resistance Mechanisms in Cancer. Cell reports, Vol.23 (10), pp. 3042-3055.  show abstract

Luczynski, M.T. Harrison, P.T. Lima, N. Krasny, L. Paul, A. Huang, P.H. (2018). Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity. Biochemical and biophysical research communications, Vol.501 (1), pp. 124-130.  show abstract

Harrison, P.T. Huang, P.H. (2018). Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance. Essays biochem, Vol.62 (4), pp. 583-593.  show abstract

Krasny, L. Bland, P. Kogata, N. Wai, P. Howard, B.A. Natrajan, R.C. Huang, P.H. (2018). SWATH mass spectrometry as a tool for quantitative profiling of the matrisome. J proteomics, Vol.189, pp. 11-22.  show abstract

Tan, A.-. Vyse, S. Huang, P.H. (2017). Exploiting receptor tyrosine kinase co-activation for cancer therapy. Drug discovery today, Vol.22 (1), pp. 72-84.

Huang, P.H. (2017). Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy. Expert review of anticancer therapy, Vol.17 (1), pp. 1-3.

Lee, A.T. Pollack, S.M. Huang, P. Jones, R.L. (2017). Phase III Soft Tissue Sarcoma Trials: Success or Failure?. Current treatment options in oncology, Vol.18 (3).

Polychronidou, G. Karavasilis, V. Pollack, S.M. Huang, P.H. Lee, A. Jones, R.L. (2017). Novel therapeutic approaches in chondrosarcoma. Future oncology (london, england), Vol.13 (7), pp. 637-648.  show abstract

Vyse, S. Desmond, H. Huang, P.H. (2017). Advances in mass spectrometry based strategies to study receptor tyrosine kinases. Iucrj, Vol.4 (Pt 2), pp. 119-130.  show abstract

Vyse, S. Howitt, A. Huang, P.H. (2017). Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer. Journal of molecular biology, Vol.429 (12), pp. 1767-1786.  show abstract

Lima, N. Lee, A. Huang, P.H. (2017). Progress and impact of clinical phosphoproteomics on precision oncology. Translational cancer research, .  show abstract

Payne, L.S. Huang, P.H. (2017). Targeted Analysis of Phosphotyrosine Signaling by Multiple Reaction Monitoring Mass Spectrometry. , , pp. 263-281.

Broncel, M. Huang, P.H. (2017). Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell Lines. , , pp. 253-262.

Lee, A. Huang, P. DeMatteo, R.P. Pollack, S.M. (2016). Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away. American society of clinical oncology educational book. american society of clinical oncology. annual meeting, Vol.35, pp. 281-290.  show abstract

Lee, A.T. Huang, P.H. Pollack, S.M. Jones, R.L. (2016). Drug repositioning in sarcomas and other rare tumors. Ebiomedicine, Vol.6, pp. 4-5.

Noujaim, J. Payne, L.S. Judson, I. Jones, R.L. Huang, P.H. (2016). Phosphoproteomics in translational research: a sarcoma perspective. Annals of oncology, Vol.27 (5), pp. 787-794.

Wong, J.P. Todd, J.R. Finetti, M.A. McCarthy, F. Broncel, M. Vyse, S. Luczynski, M.T. Crosier, S. Ryall, K.A. Holmes, K. Payne, L.S. Daley, F. Wai, P. Jenks, A. Tanos, B. Tan, A.-. Natrajan, R.C. Williamson, D. Huang, P.H. (2016). Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors. Cell reports, Vol.17 (5), pp. 1265-1275.

Maguire, S.L. Peck, B. Wai, P.T. Campbell, J. Barker, H. Gulati, A. Daley, F. Vyse, S. Huang, P. Lord, C.J. Farnie, G. Brennan, K. Natrajan, R. (2016). Three‐dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model. The journal of pathology, Vol.240 (3), pp. 315-328.

Krasny, L. Paul, A. Wai, P. Howard, B.A. Natrajan, R.C. Huang, P.H. (2016). Comparative proteomic assessment of matrisome enrichment methodologies. The biochemical journal, Vol.473 (21), pp. 3979-3995.  show abstract

Corallino, S. Iwai, L.K. Payne, L.S. Huang, P.H. Sacco, F. Cesareni, G. Castagnoli, L. (2016). Alterations in the phosphoproteomic profile of cells expressing a non-functional form of the SHP2 phosphatase. N biotechnol, Vol.33 (5 Pt A), pp. 524-536.  show abstract

Todd, J.R. Ryall, K.A. Vyse, S. Wong, J.P. Natrajan, R.C. Yuan, Y. Tan, A.-. Huang, P.H. (2016). Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer. Oncotarget, Vol.7 (39), pp. 62939-62953.  show abstract

Tan, A.C. Ryall, K.A. Huang, P.H. (2016). Expanding the computational toolbox for interrogating cancer kinomes. Pharmacogenomics, Vol.17 (2), pp. 95-97.

Huang, P.H. Cook, R. Mittnacht, S. (2015). RB in DNA repair. Oncotarget, Vol.6 (25), pp. 20746-20747.

Cook, R. Zoumpoulidou, G. Luczynski, M.T. Rieger, S. Moquet, J. Spanswick, V.J. Hartley, J.A. Rothkamm, K. Huang, P.H. Mittnacht, S. (2015). Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining. Cell rep, Vol.10 (12), pp. 2006-2018.  show abstract

Payne, L.S. Huang, P.H. (2014). Discoidin domain receptor 2 signaling networks and therapy in lung cancer. J thorac oncol, Vol.9 (6), pp. 900-904.  show abstract

Iwai, L.K. Luczynski, M.T. Huang, P.H. (2014). Discoidin domain receptors: a proteomic portrait. Cell mol life sci, Vol.71 (17), pp. 3269-3279.  show abstract

Fu, H.-. Valiathan, R.R. Payne, L. Kumarasiri, M. Mahasenan, K.V. Mobashery, S. Huang, P. Fridman, R. (2014). Glycosylation at Asn211 regulates the activation state of the discoidin domain receptor 1 (DDR1). J biol chem, Vol.289 (13), pp. 9275-9287.  show abstract

Iwai, L.K. Chang, F. Huang, P.H. (2013). Phosphoproteomic analysis identifies insulin enhancement of discoidin domain receptor 2 phosphorylation. Cell adh migr, Vol.7 (2), pp. 161-164.  show abstract

Payne, L.S. Huang, P.H. (2013). The pathobiology of collagens in glioma. Mol cancer res, Vol.11 (10), pp. 1129-1140.  show abstract

Iwai, L.K. Payne, L.S. Luczynski, M.T. Chang, F. Xu, H. Clinton, R.W. Paul, A. Esposito, E.A. Gridley, S. Leitinger, B. Naegle, K.M. Huang, P.H. (2013). Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants. Biochem j, Vol.454 (3), pp. 501-513.  show abstract

Fu, H.-. Valiathan, R.R. Arkwright, R. Sohail, A. Mihai, C. Kumarasiri, M. Mahasenan, K.V. Mobashery, S. Huang, P. Agarwal, G. Fridman, R. (2013). Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J biol chem, Vol.288 (11), pp. 7430-7437.  show abstract

Huang, P.H. (2012). Phosphoproteomic studies of receptor tyrosine kinases: future perspectives. Mol biosyst, Vol.8 (4), pp. 1100-1107.  show abstract

Hedgethorne, K. Huang, P.H. (2012). Dacomitinib Pan-ErbB inhibitor, Oncolytic. Drugs of the future, Vol.37 (6), pp. 393-401.

Xu, H. Bihan, D. Chang, F. Huang, P.H. Farndale, R.W. Leitinger, B. (2012). Discoidin domain receptors promote α1β1- and α2β1-integrin mediated cell adhesion to collagen by enhancing integrin activation. Plos one, Vol.7 (12), p. e52209.  show abstract

Suwaki, N. Vanhecke, E. Atkins, K.M. Graf, M. Swabey, K. Huang, P. Schraml, P. Moch, H. Cassidy, A.M. Brewer, D. Al-Lazikani, B. Workman, P. De-Bono, J. Kaye, S.B. Larkin, J. Gore, M.E. Sawyers, C.L. Nelson, P. Beer, T.M. Geng, H. Gao, L. Qian, D.Z. Alumkal, J.J. Thomas, G. Thomas, G.V. (2011). A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma. Sci transl med, Vol.3 (85), p. 85ra47.  show abstract

Hedgethorne, K. Huang, P.H. (2010). FORETINIB. Drugs of the future, Vol.35 (11), pp. 893-9.

Huang, P.H. Miraldi, E.R. Xu, A.M. Kundukulam, V.A. Del Rosario, A.M. Flynn, R.A. Cavenee, W.K. Furnari, F.B. White, F.M. (2010). Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol biosyst, Vol.6 (7), pp. 1227-1237.  show abstract

Xu, A.M. Huang, P.H. (2010). Receptor tyrosine kinase coactivation networks in cancer. Cancer res, Vol.70 (10), pp. 3857-3860.  show abstract

Pines, G. Huang, P.H. Zwang, Y. White, F.M. Yarden, Y. (2010). EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism. Oncogene, Vol.29 (43), pp. 5850-5860.  show abstract

Joughin, B.A. Naegle, K.M. Huang, P.H. Yaffe, M.B. Lauffenburger, D.A. White, F.M. (2009). An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cells. Mol biosyst, Vol.5 (1), pp. 59-67.  show abstract

Huang, P.H. Xu, A.M. White, F.M. (2009). Oncogenic EGFR signaling networks in glioma. Sci signal, Vol.2 (87), p. re6.  show abstract

Huang, P.H. Marais, R. (2009). Cancer: Melanoma troops massed. Nature, Vol.459 (7245), pp. 336-337.

Huang, P.H. White, F.M. (2008). Phosphoproteomics: unraveling the signaling web. Mol cell, Vol.31 (6), pp. 777-781.  show abstract

Wilker, E.W. van Vugt, M.A. Artim, S.A. Huang, P.H. Petersen, C.P. Reinhardt, H.C. Feng, Y. Sharp, P.A. Sonenberg, N. White, F.M. Yaffe, M.B. (2007). 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature, Vol.446 (7133), pp. 329-332.  show abstract

Huang, P.H. Cavenee, W.K. Furnari, F.B. White, F.M. (2007). Uncovering therapeutic targets for glioblastoma: a systems biology approach. Cell cycle, Vol.6 (22), pp. 2750-2754.  show abstract

Huang, P.H. Mukasa, A. Bonavia, R. Flynn, R.A. Brewer, Z.E. Cavenee, W.K. Furnari, F.B. White, F.M. (2007). Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc natl acad sci u s a, Vol.104 (31), pp. 12867-12872.  show abstract


Books

Tan, A.-. Huang, P.H. (2017). Kinase Signaling Networks, Humana Press, ISBN: 9781493971527.

Fridman, R. Huang, P.H. (2016). Discoidin Domain Receptors in Health and Disease, 1.Springer-Verlag New York, ISBN: 978-1-4939-6383-6.


Book Chapters

van der Laan, P. Tirotta, F. Pankova, V. Ford, S. Huang, P. van Houdt, W.J. (2022). Atypical Patterns of Metastases: How Do Sarcomas Metastasize?. Cancer Metastasis Through the Lymphovascular System. (pp. 629-637). Springer International Publishing, ISBN: 9783030930837.

Iwai, L.K. Payne, L.S. Allam, D. Huang, P.H. (2016). Discoidin Domain Receptor Signaling Networks. In Fridman, R.Huang, P.H. (Eds.), Discoidin Domain Receptors in Health and Disease. Springer-Verlag New York, ISBN: 978-1-4939-6383-6.

Huang, P.H. White, F.M. (2009). Selecting optimum combinations for therapeutic treatment of brain tumors using quantitative analysis of signaling networks. In Meir, E.G. (Ed.), CNS Cancer, Models, Prognostic Factors and Targets. (pp. 953-1284). Humana Press, ISBN: 9781603275521.

White, F.M. Huang, P.H. Farley, A. (2009). Phosphopeptide analysis using IMAC and mass spectrometry. In Link, A.J.LaBaer, J. (Eds.), Proteomics. (p. 228). Cold Spring Harbor Laboratory Pr, ISBN: 9780879697877.


Patents and patent applications

Wong, J.Huang, P.H. Methods and materials for treating cancer.

Huang, P.Cheang, M.Jones, R.Lee, A. MATERIALS AND METHODS FOR STRATIFYING AND TREATING CANCERS.